NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
52 hedge funds and large institutions have $8.72M invested in Navidea Biopharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
77% less call options, than puts
Call options by funds: $15K | Put options by funds: $66K
Holders
52
Holding in Top 10
–
Calls
$15K
Puts
$66K
Top Buyers
| 1 | +$1.81M | |
| 2 | +$146K | |
| 3 | +$42.5K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$39.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.9K |
Top Sellers
| 1 | -$272K | |
| 2 | -$201K | |
| 3 | -$191K | |
| 4 |
D.E. Shaw & Co
New York
|
-$154K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$57.9K |